UBS Group »

Bicara Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.5M 97k 15.79
2025-06-30 $814k 88k 9.29
2025-03-31 $858k 66k 13.03
2024-12-31 $3.5M 200k 17.42
2024-09-30 $71k 2.8k 25.47